Cisplatin Treatment Options

A collection of 1441 research studies where Cisplatin is the interventional treatment. These studies are located in the United States . Cisplatin is used for conditions such as Head and Neck Cancer, Lung Cancer and Non-Small Cell Lung Cancer.

Home

All Treatments

Cisplatin

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Healthy Participants Needed (Colonoscopy + Cancer Screening)

Recruiting

Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.

Conditions:

Healthy

Healthy Volunteers

Healthy Subjects

Healthy Volunteer

Healthy Participants

Learn More

Featured Trial

Buy Retatrutide Online Through Celia

Recruiting

Retatrutide (formerly M25) is an investigational peptide being studied for its potential in supporting weight management and metabolic health. It acts on GLP-1, GIP, and glucagon receptors to influence appetite, energy regulation, and fat metabolism.

Conditions:

Healthy

Learn More

Featured Offer

Lose 20% of Body Weight With GLP-1's

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to tirzepatide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

Semaglutide and Tirzepatide are advanced GLP-1 medications designed to support weight management and metabolic health. They work by targeting GLP-1 receptors in the body, helping regulate appetite, improve blood sugar control, and support sustainable weight loss (up to 22% of body weight).

Get $50 off your first order using promo code: policy-lab-50

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

Featured Trial

Birth Control Clinical Research Study

Recruiting

Living with obesity and looking for a birth control option that is right for you? Clinical trials are now enrolling women with a body mass index (BMI) of 30 or more in the area to help study a potential new progestin-only contraceptive patch. Participating in research studies can help advance birth control options. Don’t let financial stress hold you back. All study-related assessments, care, and study patch are available at no cost. You may also be reimbursed for study-related travel.

Conditions:

Obesity

Overweight

Overweight and Obesity

Learn More

Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma

NCT03389477

Active Not Recruiting

The purpose of this study is to evaluate the results of treating patients with HPV-unrelated head and neck squamous cell carcinoma with neoadjuvant single-agent palbociclib, followed by chemoradiation (either cisplatin + IMRT or cetuximab + IMRT depending on patient characteristics), followed by adjuvant single-agent palbociclib.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/01/2024

Locations: Washington University School of Medicine, Saint Louis, Missouri

Conditions: Head and Neck Squamous Cell Carcinoma

Learn More ›

Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers

NCT03515538

Completed

The purpose of this study is to determine if RRx-001, which is added on to the cisplatin and radiation treatment, reduces the duration or length of severe oral mucositis in patients with head and neck cancers. All patients in this study will receive 7 weeks of standard of care radiation therapy given with the chemotherapy agent, cisplatin. Patients in arms 1, 2 and 3 will also receive RRx-001 on different schedules.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

10/31/2024

Locations: John Wayne Cancer Institute @ Providence St. John's Health Center, Santa Monica, California +11 locations

Conditions: Oral Mucositis

Learn More ›

Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

NCT06040970

Recruiting

This is an open-label, Phase 1 study with a dose expansion cohort of Sacituzumab Govitecan in Combination with Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer. The goal of the study is to determine the optimal dose of sacituzumab govitecan for use in combination with cisplatin for treatment of epithelial ovarian and endometrial cancers.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

10/29/2024

Locations: Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology, New York, New York

Conditions: Ovarian Cancer, Malignant Neoplasm of Uterus

Learn More ›

A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer

NCT05566041

Active Not Recruiting

This Global Phase 3 study aims to find out whether RRx-001 + platinum chemotherapy is more effective than platinum chemotherapy alone in 3rd line or beyond small cell cancer.

Gender:

ALL

Ages:

Between 18 years and 80 years

Trial Updated:

10/29/2024

Locations: H. Lee Moffitt Cancer Center & Research Institute, Inc., Tampa, Florida +1 locations

Conditions: Carcinoma, Small Cell Lung

Learn More ›

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

NCT04481204

Active Not Recruiting

This is a phase II study using the Bayesian platform design. There are three clinical stage groups of localized pancreatic cancer: resectable, borderline resectable, and locally advanced disease. Each stage group will have a defined standard of care chemotherapy regimen for a control arm, serving as a basis of comparison. Each group may have one or more experimental arms. Experimental arms may be added to the platform over time, and the effects of the experimental treatments will be tested again... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

10/24/2024

Locations: M D Anderson Cancer Center, Houston, Texas

Conditions: Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma

Learn More ›

Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer

NCT03036098

Active Not Recruiting

The purpose of this study is to determine whether an investigational immunotherapy nivolumab in combination with ipilimumab or in combination with standard of care chemotherapy is more effective than standard of care chemotherapy alone in treating participants with previously untreated inoperable or metastatic urothelial cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

10/22/2024

Locations: Local Institution - 0001, Anchorage, Alaska +173 locations

Local Institution - 0001, Anchorage, Alaska

Local Institution - 0115, Fresno, California

St Joseph Heritage Healthcare, Santa Rosa, California

Local Institution - 0051, Boca Raton, Florida

Local Institution - 0087, Fort Lauderdale, Florida

Local Institution - 0062, Jacksonville, Florida

Local Institution - 0004, Athens, Georgia

Local Institution - 0033, Thomasville, Georgia

Local Institution - 0046, Chicago, Illinois

Local Institution - 0117, New Orleans, Louisiana

Local Institution - 0056, Boston, Massachusetts

Local Institution - 0073, Boston, Massachusetts

Local Institution - 0208, Boston, Massachusetts

Local Institution - 0207, Milford, Massachusetts

Local Institution - 0063, Ann Arbor, Michigan

Local Institution - 0002, Burnsville, Minnesota

Hattiesburg Clinic, Hattiesburg, Mississippi

Local Institution - 0032, Kansas City, Missouri

Local Institution - 0095, Saint Louis, Missouri

Local Institution - 0057, Manchester, New Hampshire

Local Institution - 0084, Albuquerque, New Mexico

Local Institution - 0083, Buffalo, New York

Local Institution - 0014, Mineola, New York

Local Institution - 0072, New York, New York

Local Institution - 0116, Durham, North Carolina

Local Institution - 0082, Columbus, Ohio

Local Institution - 0104, Portland, Oregon

Local Institution - 0013, Pittsburgh, Pennsylvania

Local Institution - 0086, Kirkland, Washington

Local Institution - 0005, Capital Federal, Buenos Aires

Local Institution - 0007, Mar Del Plata, Buenos Aires

Local Institution - 0008, Viedma, RIO Negro

Local Institution - 0009, Buenos Aires, Not set

Local Institution - 0134, Cordoba, Not set

Local Institution - 0006, Cordoba, Not set

Local Institution - 0096, Waratah, New South Wales

Local Institution - 0099, Westmead, New South Wales

Local Institution - 0188, South Brisbane, Queensland

Local Institution - 0120, Tugun, Queensland

Local Institution - 0101, Heidelberg, Victoria

Local Institution - 0100, Doubleview, Western Australia

Local Institution - 0017, Brasilia, Distrito Federal

Local Institution - 0021, Ijui, RIO Grande DO SUL

Local Institution - 0119, Passo Fundo, RIO Grande DO SUL

Local Institution - 0020, Porto Alegre, RIO Grande DO SUL

Local Institution - 0016, Florianopolis, Santa Catarina

Local Institution - 0018, Barretos, Sao Paulo

Local Institution - 0019, Sao Jose Do Rio Preto, Sao Paulo

Local Institution - 0053, Halifax, Nova Scotia

Local Institution - 0064, London, Ontario

Local Institution - 0054, Quebec City, Quebec

Local Institution - 0052, Sherbrooke, Quebec

Local Institution - 0010, Santiago, Metropolitana

Local Institution - 0012, Vina del Mar, Valparaiso

Local Institution - 0106, Vitacura, Not set

Local Institution - 0171, Beijing, Beijing

Local Institution - 0169, Beijing, Beijing

Local Institution - 0182, Chongqing, Chongqing

Local Institution - 0217, Guiyang, Guizhou

Local Institution - 0219, Harbin, Heilongjiang

Local Institution - 0180, Wuhan, Hubei

Local Institution - 0177, Nanjing, Jiangsu

Local Institution - 0176, Nanjing, Jiangsu

Local Institution - 0175, Nanjng, Jiangsu

Local Institution - 0186, Changchun, Jilin

Local Institution - 0220, Taiyuan, Shan1xi

Local Institution - 0216, Yantai, Shandong

Local Institution - 0167, Shanghai, Shanghai

Local Institution - 0162, Shanghai, Shanghai

Local Institution - 0163, Shanghai, Shanghai

Local Institution - 0184, Chengdu, Sichuan

Local Institution - 0173, Hangzhou, Zhejiang

Local Institution - 0174, Hangzhou, Zhejiang

Local Institution - 0172, Hangzhou, Zhejiang

Local Institution - 0170, Beijing, Not set

Local Institution - 0164, Shanghai, Not set

Local Institution - 0160, Brno, Not set

Local Institution - 0152, Hradec Kralove, Not set

Local Institution - 0190, Aalborg, Not set

Local Institution - 0196, Herlev, Not set

Local Institution - 0060, Helsinki, Not set

Local Institution - 0091, Nîmes, Gard

Local Institution - 0089, Lille, Not set

Local Institution - 0088, Marseille Cedex 9, Not set

Local Institution - 0090, St Priest En Jarez, Not set

Local Institution - 0092, Suresnes, Not set

Local Institution - 0093, Tours Cedex, Not set

Local Institution - 0094, Villejuif, Not set

Local Institution - 0036, Dresden, Not set

Local Institution - 0048, Essen, Not set

Local Institution - 0047, Freiburg, Not set

Local Institution - 0049, Hamburg, Not set

Local Institution - 0037, Hannover, Not set

Local Institution - 0041, Jena, Not set

Local Institution - 0213, Mannheim, Not set

Local Institution - 0038, Nuernberg, Not set

Local Institution - 0040, Tuebingen, Not set

Local Institution - 0114, Weiden, Not set

Local Institution - 0039, Wuerzburg, Not set

Local Institution - 0102, Athens, Not set

Local Institution - 0103, Ioannina, Ípeiros

Local Institution - 0199, Kfar Saba, Not set

Local Institution - 0198, Ramat Gan, Not set

Local Institution - 0108, Arezzo, Not set

Local Institution - 0197, Faenza, Not set

Local Institution - 0111, Forlì, Not set

Local Institution - 0109, Grosseto, Not set

Local Institution - 0107, Milano, Not set

Local Institution - 0110, Napoli, Not set

Local Institution - 0136, Hirosaki, Aomori

Local Institution - 0135, Chiba-shi, Chiba

Local Institution - 0147, Matsuyama-shi, Ehime

Local Institution - 0140, Fukuoka-shi, Fukuoka

Local Institution - 0146, Sapporo-city, Hokkaido

Local Institution - 0150, Tsukuba-shi, Ibaraki

Local Institution - 0214, Morioka-shi, Iwate

Local Institution - 0137, Kita-Gun, Kagawa

Local Institution - 0141, Niigata-shi, Niigata

Local Institution - 0143, Okayama-shi, Okayama

Local Institution - 0144, Osaka-shi, Osaka

Local Institution - 0139, Osakasayama, Osaka

Local Institution - 0145, Takatsuki-shi, Osaka

Local Institution - 0201, Hamamatasu, Shizuoka

Local Institution - 0149, Adachi-ku, Tokyo

Local Institution - 0148, Bunkyo-ku, Tokyo

Local Institution - 0142, Bunkyo-ku, Tokyo

Local Institution - 0138, Shinjuku-Ku, Tokyo

Local Institution - 0215, Wakayama-shi, Wakayama

Local Institution - 0200, Ube City, Yamaguchi

Local Institution - 0125, Goyang-si, Gyeonggido

Local Institution - 0126, Seongnam-si, Not set

Local Institution - 0124, Seoul, Not set

Local Institution - 0151, Seoul, Not set

Local Institution - 0128, Seoul, Not set

Local Institution - 0127, Seoul, Not set

Local Institution - 0129, Ciudad de Mexico, Distrito Federal

Local Institution - 0154, Mexico City, Distrito Federal

Local Institution - 0130, Tlalpan, Distrito Federal

Local Institution - 0131, Monterrey, Nuevo Leon

Local Institution - 0022, Amsterdam, Noord-Holland

Local Institution - 0055, Enschede, Not set

Local Institution - 0024, Groningen, Not set

Local Institution - 0026, Leeuwarden, Not set

Local Institution - 0074, Bergen, Not set

Local Institution - 0081, Lorenskog, Not set

Local Institution - 0030, Lima, Not set

Local Institution - 0031, Lima, Not set

Local Institution - 0189, Bydgoszcz, Not set

Local Institution - 0205, Koszalin, Not set

Local Institution - 0202, Warszawa, Not set

Local Institution - 0191, Cluj-Napoca, Cluj

Local Institution - 0187, Craiova, Dolj

Local Institution, Moscow, Not set

Local Institution - 0192, Singapore, Central Singapore

Local Institution - 0070, A Coruna, Not set

Local Institution - 0068, Barcelona, Not set

Local Institution - 0065, Madrid, Not set

Local Institution - 0066, Madrid, Not set

Local Institution - 0209, Santander, Not set

Local Institution - 0067, Sevilla, Not set

Local Institution - 0069, Valencia, Not set

Local Institution - 0075, Jonkoping, Not set

Local Institution - 0059, Linkoping, Not set

Local Institution - 0058, Lund, Not set

Local Institution - 0061, Baden, Aargau

Local Institution - 0042, Chur, Not set

Local Institution - 0156, Kaohsiung, Not set

Local Institution - 0159, Taichung, Not set

Local Institution - 0158, Taipei, Not set

Local Institution - 0155, Taipei, Not set

Local Institution - 0157, Taoyuan, Not set

Local Institution - 0194, Ankara, Not set

Local Institution - 0204, Istanbul, Not set

Local Institution - 0193, Izmir, Not set

Conditions: Urothelial Cancer

Learn More ›

Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa

NCT01670500

Completed

This research study is a Phase II clinical trial. Phase II clinical trials test the effectiveness of an investigational drug, which is cisplatin in this trial, to learn how well it works in treating a specific cancer. "Investigational" means that cisplatin is still being studied for use in this setting and that research doctors are trying to find out more about it-in this case, how effective cisplatin is for treating breast cancer in BRCA mutation carriers. It also means that the FDA has not yet... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

10/22/2024

Locations: University of Colorado Cancer Center, Aurora, Colorado +14 locations

Conditions: Breast Cancer

Learn More ›

Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)

NCT05186974

Active Not Recruiting

The goal of this clinical study is to learn more about the study drug, sacituzumab govitecan-hziy (SG), and its dosing in combination with pembrolizumab or pembrolizumab and a platinum agent (carboplatin or cisplatin), in participants with advanced or metastatic (cancer that has spread) non-small-cell lung cancer (NSCLC).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

10/18/2024

Locations: Alaska Oncology and Hematology, LLC., Anchorage, Alaska +100 locations

Alaska Oncology and Hematology, LLC., Anchorage, Alaska

Beverly Hills Cancer Center, Beverly Hills, California

USC/Norris Comprehensive Cancer Center, Los Angeles, California

UCLA Hematology/Oncology - Santa Monica, Los Angeles, California

UC Irvine Health, Orange, California

Stanford Cancer Institute, Stanford, California

University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora, Colorado

Georgetown University Medical Center, Washington, District of Columbia

Moffitt Cancer Center, Tampa, Florida

Northside Hospital Central Research Department, Atlanta, Georgia

Northwestern Memorial Hospital, Chicago, Illinois

Rush University Medical Center, Chicago, Illinois

Orchard Healthcare Research Inc., Skokie, Illinois

Kansas City Veterans Affairs Medical Center, Westwood, Kansas

Kansas City VA Medical Center, Kansas City, Missouri

Weill Cornell Medical/New York-Presbyterian Hospital, New York, New York

Great Lakes Cancer Care, Williamsville, New York

Wake Forest Baptist Health - High Point Medical Center, High Point, North Carolina

FirstHealth Outpatient Cancer Center, Pinehurst, North Carolina

University Hospital Cleveland Medical Center, Cleveland, Ohio

OSU Brain & Spine Hospital, Columbus, Ohio

Siouxland Regional Cancer Center dba June E. Nylen Cancer Center, North Sioux City, South Dakota

Southern Highlands Cancer Centre, Bowral, New South Wales

Saint Vincents Hospital Sydney, Darlinghurst, New South Wales

St George Private Hospital, Kogarah, New South Wales

Pindara Private Hospital, Benowa, Queensland

Sunshine Coast University Private Hospital, Birtinya, Queensland

Flinders Medical Centre, Bedford Park, South Australia

Ashford Cancer Centre Research, Windsor Gardens, South Australia

Peninsula Health - Frankston Hospital, Frankston, Victoria

Western Health - Sunshine Hospital, Melbourne, Victoria

Joondalup Health Campus, Joondalup, Western Australia

CIUSSS Saguenay Lac St-Jean, Quebec, Not set

McGill University Health Centre, Quebec, Not set

APHP - Hôpital Ambroise Paré, Boulogne-Billancourt, Not set

CHRU de Brest - Hopital Morvan, Brest, Not set

Centre Francois Baclesse, Caen, Not set

CHU de CAEN, Caen, Not set

Centre Jean Perrin - 58 rue Montalembert, Clermont-Ferrand, Not set

Centre Georges-François Leclerc, Dijon, Not set

Clinique Victor Hugo, Le Mans, Not set

Institut Curie, Paris, Not set

CHU de Bordeaux Hopital Haut leveque, Pessac, Not set

Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre Benite, Not set

Institut de Cancérologie de l'Ouest, Saint Herblain, Not set

Evangelische Lungenklinik Berlin Krakenhausbetriebs GmBH, Berlin, Not set

Klinikum Chemnitz gGmbH, Chemnitz, Not set

Universitatsklinikum Koln, Klinik I fur Innere Medizin, Cologne, Not set

Klinikum Esslingen GmbH, Klinik fur Kardiologie, Angiologie und Pneumologie, Esslingen, Not set

Universitatsklinikum Frankfurt, Frankfurt, Not set

Asklepios Fachkliniken Munchen-Gauting, Zentrum fur Pneumologie und Thoraxchirugie, Gauting, Not set

LungenClinic Grosshansdorf, Grosshansdorf, Not set

Martha-Maria Krankenhaus Halle Dölau gGmbH, Halle, Not set

LKI Lungenfachklinik Immenhausen, Immenhausen, Not set

Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, Not set

Queen Elizabeth Hospital, Hong Kong, Not set

Queen Mary Hospital, Hong Kong, Not set

Hong Kong United Oncology Center, Kowloon, Not set

ASST Spedali Civili di Brescia, Brescia, Not set

AOU Policlinico Vittorio Emanuele - POG Rodolico, Catania, Not set

Azienda Ospedaliero-Universitaria di Parma, Parma, Not set

IRCCS Istituti Fisioterapicic Ospitalieri - Istituto Nazionale Tumori Regina Elena, Rome, Not set

IRCCS Instituto Clinico Humanitas, Rozzano, Not set

Chungbuk National University Hospital, Cheongju-si, Not set

Gachon University Gil Medical Center, Inchon, Not set

Asan Medical Center, Seoul, Not set

Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul, Not set

Severance Hospital, Yonsei University Health System, Seoul, Not set

The Catholic University of Korea St. Vincent's Hospital, Suwon, Not set

Sultan Ismail Hospital, Johor Bahru, Not set

Hospital Raja Perempuan Zainab II, Kota Bharu, Not set

Hospital Kuala Lumpur, Kuala Lumpur, Not set

University Malaya Medical Centre, Kuala Lumpur, Not set

Hospital Tengku Ampuan Afzan, Kuantan, Not set

Sarawak General Hospital, Kuching, Not set

Institut Kanser Negara, Putrajaya, Not set

Complejo Hospitalario Universitario A Coruna. Hospital Teresa Herrera, A coruna, Not set

Hospital Universitari Germans Trias i Pujol, Badalona, Not set

Hospital Universitari Vall d'Hebrón, Barcelona, Not set

Hospital Clinic de Barcelona, Barcelona, Not set

Hospital Duran i Reynals, Barcelona, Not set

Hospital General Universitario Gregorio Maranon, Madrid, Not set

Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda, Not set

Clinica Universidad de Navarra - Pamplona, Pamplona, Not set

Hospital Regional Universitario de Malaga-Hospital Civil, Rincon de la Victoria, Not set

Complejo Hospitalario Universitario de Santiago de Compostela CHUS_Hospital Clinico Universitario, Santiago de Compostela, Not set

Hospital Universitario Virgen de Valme, Sevilla, Not set

Hospital Universitario Virgen Macarena, Sevilla, Not set

Hospital Universitari i Politecnic La Fe, Valencia, Not set

Changhua Christian Hospital, Changhua City, Not set

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Not set

E-DA Hospital, Kaohsiung City, Not set

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Not set

Chi Mei Hospital - Liouying, Liouying Dist., Not set

National Cheng Kung University Hospital, Tainan City, Not set

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei City, Not set

National Taiwan University Hospital, Taipei City, Not set

Taipei Veterans General Hospital, Taipei, Not set

Chang Gung Memorial Hospital (CGMH), Taoyuan City, Not set

University Hospitals Birmingham NHS Foundation Trust, Birmingham, Not set

Guy's and St Thomas' NHS Foundation Trust, London, Not set

Conditions: Non-small Cell Lung Cancer

Learn More ›

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

NCT01096368

Active Not Recruiting

The primary aim of this randomized phase III trial was to study whether the addition of maintenance chemotherapy delivered after surgical resection and focal radiation would be better than surgery and focal radiation alone. The trial also studied if patients who received induction chemotherapy and then either achieved a complete response or went on to have a complete resection would also benefit from maintenance chemotherapy. Children ages 1-21 years with newly diagnosed intracranial ependymoma... Read More

Gender:

ALL

Ages:

Between 12 months and 21 years

Trial Updated:

10/16/2024

Locations: Children's Hospital of Alabama, Birmingham, Alabama +208 locations

Children's Hospital of Alabama, Birmingham, Alabama

University of Alabama at Birmingham Cancer Center, Birmingham, Alabama

Banner Children's at Desert, Mesa, Arizona

Phoenix Childrens Hospital, Phoenix, Arizona

Banner University Medical Center - Tucson, Tucson, Arizona

Arkansas Children's Hospital, Little Rock, Arkansas

University of Arkansas for Medical Sciences, Little Rock, Arkansas

Kaiser Permanente Downey Medical Center, Downey, California

City of Hope Comprehensive Cancer Center, Duarte, California

Loma Linda University Medical Center, Loma Linda, California

Miller Children's and Women's Hospital Long Beach, Long Beach, California

Children's Hospital Los Angeles, Los Angeles, California

Cedars Sinai Medical Center, Los Angeles, California

Valley Children's Hospital, Madera, California

UCSF Benioff Children's Hospital Oakland, Oakland, California

Kaiser Permanente-Oakland, Oakland, California

Children's Hospital of Orange County, Orange, California

Lucile Packard Children's Hospital Stanford University, Palo Alto, California

Sutter Medical Center Sacramento, Sacramento, California

University of California Davis Comprehensive Cancer Center, Sacramento, California

Rady Children's Hospital - San Diego, San Diego, California

UCSF Medical Center-Parnassus, San Francisco, California

UCSF Medical Center-Mission Bay, San Francisco, California

Children's Hospital Colorado, Aurora, Colorado

Connecticut Children's Medical Center, Hartford, Connecticut

Yale University, New Haven, Connecticut

Alfred I duPont Hospital for Children, Wilmington, Delaware

MedStar Georgetown University Hospital, Washington, District of Columbia

Children's National Medical Center, Washington, District of Columbia

Broward Health Medical Center, Fort Lauderdale, Florida

Lee Memorial Health System, Fort Myers, Florida

Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida

University of Florida Health Science Center - Gainesville, Gainesville, Florida

Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida

Nemours Children's Clinic-Jacksonville, Jacksonville, Florida

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida

Nicklaus Children's Hospital, Miami, Florida

AdventHealth Orlando, Orlando, Florida

Arnold Palmer Hospital for Children, Orlando, Florida

Nemours Children's Clinic - Orlando, Orlando, Florida

Orlando Health Cancer Institute, Orlando, Florida

Nemours Children's Hospital, Orlando, Florida

Nemours Children's Clinic - Pensacola, Pensacola, Florida

Johns Hopkins All Children's Hospital, Saint Petersburg, Florida

Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida

Saint Mary's Hospital, West Palm Beach, Florida

Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia

Augusta University Medical Center, Augusta, Georgia

Memorial Health University Medical Center, Savannah, Georgia

Kapiolani Medical Center for Women and Children, Honolulu, Hawaii

Saint Luke's Cancer Institute - Boise, Boise, Idaho

Lurie Children's Hospital-Chicago, Chicago, Illinois

University of Illinois, Chicago, Illinois

University of Chicago Comprehensive Cancer Center, Chicago, Illinois

Loyola University Medical Center, Maywood, Illinois

Advocate Children's Hospital-Oak Lawn, Oak Lawn, Illinois

Saint Jude Midwest Affiliate, Peoria, Illinois

Southern Illinois University School of Medicine, Springfield, Illinois

Riley Hospital for Children, Indianapolis, Indiana

Ascension Saint Vincent Indianapolis Hospital, Indianapolis, Indiana

Blank Children's Hospital, Des Moines, Iowa

University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa

University of Kentucky/Markey Cancer Center, Lexington, Kentucky

Norton Children's Hospital, Louisville, Kentucky

Tulane University Health Sciences Center, New Orleans, Louisiana

Children's Hospital New Orleans, New Orleans, Louisiana

Ochsner Medical Center Jefferson, New Orleans, Louisiana

Eastern Maine Medical Center, Bangor, Maine

Maine Children's Cancer Program, Scarborough, Maine

University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland

Walter Reed National Military Medical Center, Bethesda, Maryland

Tufts Children's Hospital, Boston, Massachusetts

Massachusetts General Hospital Cancer Center, Boston, Massachusetts

Dana-Farber Cancer Institute, Boston, Massachusetts

Baystate Medical Center, Springfield, Massachusetts

C S Mott Children's Hospital, Ann Arbor, Michigan

Wayne State University/Karmanos Cancer Institute, Detroit, Michigan

Ascension Saint John Hospital, Detroit, Michigan

Michigan State University Clinical Center, East Lansing, Michigan

Hurley Medical Center, Flint, Michigan

Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan

Bronson Methodist Hospital, Kalamazoo, Michigan

Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota

University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota

Mayo Clinic in Rochester, Rochester, Minnesota

University of Mississippi Medical Center, Jackson, Mississippi

Columbia Regional, Columbia, Missouri

Children's Mercy Hospitals and Clinics, Kansas City, Missouri

Cardinal Glennon Children's Medical Center, Saint Louis, Missouri

Washington University School of Medicine, Saint Louis, Missouri

Mercy Hospital Saint Louis, Saint Louis, Missouri

Children's Hospital and Medical Center of Omaha, Omaha, Nebraska

University of Nebraska Medical Center, Omaha, Nebraska

University Medical Center of Southern Nevada, Las Vegas, Nevada

Sunrise Hospital and Medical Center, Las Vegas, Nevada

Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada

Summerlin Hospital Medical Center, Las Vegas, Nevada

Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire

Hackensack University Medical Center, Hackensack, New Jersey

Saint Barnabas Medical Center, Livingston, New Jersey

Morristown Medical Center, Morristown, New Jersey

Saint Peter's University Hospital, New Brunswick, New Jersey

Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey

Newark Beth Israel Medical Center, Newark, New Jersey

Saint Joseph's Regional Medical Center, Paterson, New Jersey

Overlook Hospital, Summit, New Jersey

University of New Mexico Cancer Center, Albuquerque, New Mexico

Albany Medical Center, Albany, New York

Montefiore Medical Center - Moses Campus, Bronx, New York

Roswell Park Cancer Institute, Buffalo, New York

NYU Winthrop Hospital, Mineola, New York

The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York

Mount Sinai Hospital, New York, New York

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

University of Rochester, Rochester, New York

State University of New York Upstate Medical University, Syracuse, New York

New York Medical College, Valhalla, New York

UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina

Novant Health Presbyterian Medical Center, Charlotte, North Carolina

Wake Forest University Health Sciences, Winston-Salem, North Carolina

Sanford Broadway Medical Center, Fargo, North Dakota

Children's Hospital Medical Center of Akron, Akron, Ohio

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Rainbow Babies and Childrens Hospital, Cleveland, Ohio

Cleveland Clinic Foundation, Cleveland, Ohio

Nationwide Children's Hospital, Columbus, Ohio

Dayton Children's Hospital, Dayton, Ohio

ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio

Mercy Children's Hospital, Toledo, Ohio

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Legacy Emanuel Children's Hospital, Portland, Oregon

Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania

Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania

Geisinger Medical Center, Danville, Pennsylvania

Penn State Children's Hospital, Hershey, Pennsylvania

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania

Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania

Rhode Island Hospital, Providence, Rhode Island

Medical University of South Carolina, Charleston, South Carolina

Prisma Health Richland Hospital, Columbia, South Carolina

BI-LO Charities Children's Cancer Center, Greenville, South Carolina

Greenville Cancer Treatment Center, Greenville, South Carolina

Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota

T C Thompson Children's Hospital, Chattanooga, Tennessee

East Tennessee Childrens Hospital, Knoxville, Tennessee

Saint Jude Children's Research Hospital, Memphis, Tennessee

The Children's Hospital at TriStar Centennial, Nashville, Tennessee

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee

Dell Children's Medical Center of Central Texas, Austin, Texas

Driscoll Children's Hospital, Corpus Christi, Texas

Medical City Dallas Hospital, Dallas, Texas

Cook Children's Medical Center, Fort Worth, Texas

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas

Covenant Children's Hospital, Lubbock, Texas

UMC Cancer Center / UMC Health System, Lubbock, Texas

Children's Hospital of San Antonio, San Antonio, Texas

Methodist Children's Hospital of South Texas, San Antonio, Texas

University of Texas Health Science Center at San Antonio, San Antonio, Texas

Scott and White Memorial Hospital, Temple, Texas

Primary Children's Hospital, Salt Lake City, Utah

University of Vermont and State Agricultural College, Burlington, Vermont

Inova Fairfax Hospital, Falls Church, Virginia

Children's Hospital of The King's Daughters, Norfolk, Virginia

Naval Medical Center - Portsmouth, Portsmouth, Virginia

Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia

Carilion Children's, Roanoke, Virginia

Seattle Children's Hospital, Seattle, Washington

Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington

Mary Bridge Children's Hospital and Health Center, Tacoma, Washington

Madigan Army Medical Center, Tacoma, Washington

West Virginia University Charleston Division, Charleston, West Virginia

West Virginia University Healthcare, Morgantown, West Virginia

Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin

University of Wisconsin Carbone Cancer Center, Madison, Wisconsin

Marshfield Medical Center-Marshfield, Marshfield, Wisconsin

Children's Hospital of Wisconsin, Milwaukee, Wisconsin

John Hunter Children's Hospital, Hunter Regional Mail Centre, New South Wales

Sydney Children's Hospital, Randwick, New South Wales

The Children's Hospital at Westmead, Westmead, New South Wales

Royal Brisbane and Women's Hospital, Herston, Queensland

Royal Children's Hospital-Brisbane, Herston, Queensland

Queensland Children's Hospital, South Brisbane, Queensland

Women's and Children's Hospital-Adelaide, North Adelaide, South Australia

Monash Medical Center-Clayton Campus, Clayton, Victoria

Royal Children's Hospital, Parkville, Victoria

Princess Margaret Hospital for Children, Perth, Western Australia

Perth Children's Hospital, Perth, Western Australia

Alberta Children's Hospital, Calgary, Alberta

University of Alberta Hospital, Edmonton, Alberta

British Columbia Children's Hospital, Vancouver, British Columbia

CancerCare Manitoba, Winnipeg, Manitoba

Janeway Child Health Centre, Saint John's, Newfoundland and Labrador

IWK Health Centre, Halifax, Nova Scotia

McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario

Kingston Health Sciences Centre, Kingston, Ontario

Children's Hospital, London, Ontario

Children's Hospital of Eastern Ontario, Ottawa, Ontario

Hospital for Sick Children, Toronto, Ontario

The Montreal Children's Hospital of the MUHC, Montreal, Quebec

Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec

Saskatoon Cancer Centre, Saskatoon, Saskatchewan

CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL), Quebec, Not set

Starship Children's Hospital, Grafton, Auckland

Christchurch Hospital, Christchurch, Not set

Conditions: Anaplastic Ependymoma, Brain Ependymoma, Cellular Ependymoma, Clear Cell Ependymoma, Ependymoma, Papillary Ependymoma

Learn More ›

Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma

NCT04854499

Terminated

The goals of this clinical study are to learn about the safety, tolerability, dosing and effectiveness of the study drug, magrolimab in combination with other anticancer therapies in patients with head and neck squamous cell carcinoma (HNSCC).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

10/11/2024

Locations: Ironwood Cancer and Research Center, Chandler, Arizona +87 locations

Ironwood Cancer and Research Center, Chandler, Arizona

City of Hope, Duarte, California

UCLA Hematology/Oncology, Los Angeles, California

Stanford Cancer Institute, Palo Alto, California

Torrance Memorial Physician Network - Cancer Care Associates, Redondo Beach, California

Providence Medical Foundation, Santa Rosa, California

Memorial Healthcare System, Hollywood, Florida

Ocala Oncology Center, Ocala, Florida

University Center and Blood Center,LLC., Athens, Georgia

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana

Virginia Piper Cancer Center (Alliant Health, Minneapolis, Minnesota

Washington University of Medicine- Siteman Cancer Center, Saint Louis, Missouri

Astera Cancer Care, East Brunswick, New Jersey

Icahn School of Medicine at Mount Sinai and the Mount Sinai Hospital, New York, New York

New York Cancer and Blood Specialists, Port Jefferson Station, New York

Sanford Roger Maris Cancer Center, Fargo, North Dakota

OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma

Lancaster General Hospital, Lancaster, Pennsylvania

Medical University of South Carolina, Charleston, South Carolina

Avera Cancer Institute, Sioux Falls, South Dakota

MD Anderson Cancer Center, Houston, Texas

Huntsman Cancer Institute, Salt Lake City, Utah

St. Vincent's Hospital Sydney, Darlinghurst, New South Wales

Macquarie University, Macquarie Park, New South Wales

Blacktown Hospital, Westmead, New South Wales

Cairns Hospital, Cairns, Queensland

University of the Sunshine Coast, Sippy Downs, Queensland

Princess Alexandra Hospital, Woolloongabba, Queensland

Austin Health, Heidelberg, Victoria

Alfred Health, Melbourne, Victoria

ZiekenhuisNetwerk Antwerpen (ZNA) - Stuivenberg, Antwerpen, Not set

Algemeen Ziekenhuis Klina, Brasschaat, Not set

UZ Antwerpen, Edegem, Not set

Universitaire Ziekenhuis Leuven, Leuven, Not set

Centre Hospitalizer De L'Ardenne, Libramont-Chevigny, Not set

AZ Sint-Maarten, Mechelen, Not set

CHU UCL Namur - Sainte-Elisabeth, Namur, Not set

Institut Bergonie, Bordeaux, Not set

Centre Georges François Leclerc, Dijon, Not set

Centre Léon Bérard, Lyon, Not set

Hopital de la Timone, Marseille, Not set

Centre de Lutte Contre le Cancer (CLCC) - Centre Antoine Lacassagne (CAL) - Site Est, Nice, Not set

Institut Curie, Paris, Not set

Hopital Pitie-Salpetriere, Paris, Not set

Civils de Lyon-Centre Hopitalier Lyon Sud, Pierre-benite, Not set

Hopital Foch, Suresnes, Not set

Institut Gustave Roussy, Villejuif, Not set

Charite University Medicine, Berlin, Not set

UniversitÃ¤tsklinikum Bonn, Medizinische Klinik und Poliklinik III, Bonn, Not set

Universitatsmedizin Gottingen, GÃttingen, Not set

Kath. Marienkrankenhaus gGmbH, Hamburg, Not set

Universitäres Krebszentrum Leipzig, Leipzig, Not set

Technische Universitat Munchen (TUM) - Klinikum Rechts der Isar, Munich, Not set

Queen Mary Hospital, Hong Kong, Not set

Princess Margaret Hospital, Lai Chi Kok, Not set

Azienda Ospedaliero - Universitaria di Bologna - IRCCS, Bologna, Not set

ASST degli Spedali Civili di Brescia, Brescia, Not set

Ospedale San Luca Luca, Lucca, Not set

Fondazione IRCCS Istituto Nazionale Tumori Milano, Milan, Not set

Azienda Ospedaliero-Universitaria di Modena - Policlinico, Modena, Not set

Arcispedale Santa Maria Nuova, Reggio Emilia, Not set

Azienda Ospedaliero - Universitaria Senese, Siena, Not set

Centrum Onkologii im. Prof. Franciszka Lukaszczyka w Bydgoszczy, Bydgoszcz, Not set

Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie, Panstwowy Instytut Badawczy, Oddzial x Gliwicach, Gliwice, Not set

Wielkopolskie Centrum Onkologii im. Marii Sklodowskiej-Curie, Oddzial Onkologii Klinicznej i Immunookologii z Poddoddzialem Dziennym i Izba Przyjec, Poznan, Not set

Wojewodzki Szpital Specjalistyczny w Siedlcach, Siedlce, Not set

Narodowy Instytut Onkologii im. M. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Klinika Nowotworow Glowy i Szyi, Warsaw, Not set

Hospital de Braga, Braga, Not set

Centro Hospitalar do Algarve, Faro, Not set

Hospital CUF Descobertas, Lisboa, Not set

Unidade Local de Saude de Matosinhos EPE - Hospital Pedro Hispano SA, Matosinhos, Not set

Centro Hospitalar Universitario do Porto, Porto, Not set

Instituto Portugues de Oncologia Do Porto Francisco Gentil,E.P.E., Porto, Not set

Hospital Universitari Vall d'Hebron, Barcelona, Not set

Hospital del Mar, Barcelona, Not set

Hospital De La Santa Creu I Sant Pau, Barcelona, Not set

Hospital Universitario de Jaen, Jaen, Not set

Hospital General Universitario Gregorio Maranon, Madrid, Not set

MD Anderson Cancer Center, Madrid, Not set

Hospital Universitario La Paz, Madrid, Not set

Hospital Regional Universitario de Malaga, Malaga, Not set

Clinica Universidad de Navarra, Pamplona, Not set

Hospital Universitario Virgen Macarena, Sevilla, Not set

Hospital Universitario Virgen del Rocio, Sevilla, Not set

Hospital Universitari i Politecnic La Fe, Valencia, Not set

Hospital Clínico Universitario de Valencia, Valencia, Not set

Royal Marsden NHS Foundation Trust, Royal Marsden - Sutton, London, Not set

Musgrove Park Hospital, Taunton, Not set

Conditions: Head and Neck Squamous Cell Carcinoma

Learn More ›

A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

NCT06094296

Completed

The purpose of this study is to evaluate the efficacy and safety of BMS-986315 plus nivolumab in combination with platinum-based doublet chemotherapy (PDCT) versus nivolumab in combination with PDCT in the first-line treatment of Stage IV or recurrent non-small cell lung cancer (NSCLC).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

10/10/2024

Locations: Local Institution - 0038, Glendale, California +7 locations

Conditions: NSCLC

Learn More ›

First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590)

NCT03189719

Completed

The purpose of this trial is to evaluate efficacy and safety of pembrolizumab plus standard of care (SOC) chemotherapy with cisplatin and 5-fluorouracil (5-FU) versus placebo plus SOC chemotherapy with cisplatin and 5-FU as first-line treatment in participants with locally advanced or metastatic esophageal carcinoma. The overall primary efficacy hypotheses are as follows: 1. In participants with esophageal squamous cell carcinoma (ESCC), participants whose tumors are programmed cell death-liga... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

10/10/2024

Locations: Kaiser Permanente Southern California ( Site 0003), West Los Angeles, California +188 locations

Kaiser Permanente Southern California ( Site 0003), West Los Angeles, California

The University of Chicago Medical Center ( Site 0001), Chicago, Illinois

University of Kansas ( Site 0029), Westwood, Kansas

University of Maryland Medical Center ( Site 0013), Baltimore, Maryland

Dana Farber Cancer Center ( Site 0009), Boston, Massachusetts

Henry Ford Cancer Center ( Site 0018), Detroit, Michigan

Washington University School of Medicine ( Site 0031), Saint Louis, Missouri

Roswell Park Cancer Institute ( Site 0004), Buffalo, New York

Weill Cornell Medical College ( Site 0024), New York, New York

University Hospitals Cleveland Medical Center ( Site 0002), Cleveland, Ohio

UPMC Cancer Center/Hillman Cancer Center ( Site 0015), Pittsburgh, Pennsylvania

University of Tennessee Medical Center Knoxville ( Site 0017), Knoxville, Tennessee

Centro de Investigaciones Clinicas - Clinica Viedma ( Site 0603), Viedma, Rio Negro

Hospital Aleman ( Site 0605), Buenos Aires, Not set

Hospital Municipal de Gastroenterologia Dr. Bonorino Udaondo ( Site 0602), Buenos Aires, Not set

Sanatorio Allende - Cordoba ( Site 0604), Cordoba, Not set

Hospital Privado Centro Medico Cordoba ( Site 0601), Cordoba, Not set

Blacktown Hospital ( Site 2000), Blacktown, New South Wales

Liverpool Hospital. ( Site 2001), Liverpool, New South Wales

Princess Alexandra Hospital ( Site 2005), Woolloongabba, Queensland

Eastern Health ( Site 2002), Box Hill, Victoria

Peter MacCallum Cancer Centre ( Site 2003), Melbourne, Victoria

CETUS Hospital Dia Oncologia ( Site 0208), Belo Horizonte, Minas Gerais

Inst de Medicina Integral Professor Fernando Figueira- IMIP ( Site 0210), Recife, Pernambuco

Clinica de Hematologia e Oncologia Viver Ltda ( Site 0211), Santa Maria, Rio Grande Do Sul

Instituto Nacional do Cancer Jose Alencar Gomes da Silva INCA ( Site 0209), Rio de Janeiro, RJ

Hospital Sao Vicente de Paulo ( Site 0204), Passo Fundo, RS

Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs ( Site 0201), Porto Alegre, RS

Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto. ( Site 0203), Sao Jose do Rio Preto, Sao Paulo

Hospital Alemao Oswaldo Cruz ( Site 0207), Sao Paulo, SP

Hospital de Clinicas de Porto Alegre ( Site 0200), Porto Alegre, Not set

Instituto do Cancer de Sao Paulo - ICESP ( Site 0206), Sao Paulo, Not set

Tom Baker Cancer Centre ( Site 0503), Calgary, Alberta

Cross Cancer Institute ( Site 0502), Edmonton, Alberta

CancerCare Manitoba ( Site 0500), Winnipeg, Manitoba

Juravinski Cancer Center ( Site 0508), Hamilton, Ontario

The Ottawa Hospital - Cancer Care ( Site 0501), Ottawa, Ontario

Princess Margaret Cancer Centre ( Site 0505), Toronto, Ontario

CISSS de la Monteregie-Centre ( Site 0504), Greenfield Park, Quebec

Jewish General Hospital ( Site 0507), Montreal, Quebec

Hospital Regional de Concepcion Dr. Guillermo Grant Benavente ( Site 1003), Concepcion, Not set

Pontificia Universidad Catolica de Chile ( Site 1001), Santiago, Not set

Hospital Clinico Universidad de Chile ( Site 1002), Santiago, Not set

Clinica Alemana de Temuco ( Site 1006), Temuco, Not set

Anhui Provincial Hospital ( Site 0106), Hefei, Anhui

The First Affiliated Hospital of Anhui Medical University ( Site 0112), Hefei, Anhui

Peking Union Medical College Hospital ( Site 0123), Beijing, Beijing

The First Affiliated Hospital of Xiamen University ( Site 0119), Xiamen, Fujian

Guangdong General Hospital ( Site 0103), Guangzhou, Guangdong

The Affiliated Tumour Hospital of Harbin Medical University ( Site 0102), Harbin, Heilongjiang

Tongji Medical College Huazhong University of Science and Technology ( Site 0109), Wuhan, Hubei

Hunan Cancer Hospital ( Site 0105), Changsha, Hunan

PLA Cancer Centre of Nanjing Bayi Hospital ( Site 0110), Nanjing, Jiangsu

Zhongda Hospital Southeast University ( Site 0125), Nanjing, Jiangsu

Jilin Cancer Hospital ( Site 0101), Changchun, Jilin

The First Affiliated Hospital of Xi an Jiaotong University ( Site 0120), Xi'an, Shannxi

Zhejiang Cancer Hospital ( Site 0116), Hangzhou, Zhejiang

Beijing Cancer Hospital ( Site 0100), Beijing, Not set

Fujian Provincial Cancer Hospital ( Site 0104), Fuzhou, Not set

Shanghai Chest Hospital ( Site 0111), Shanghai, Not set

Fudan University Shanghai Cancer Center ( Site 0108), Shanghai, Not set

Renji Hospital Shanghai Jiaotong University School of Medicine ( Site 0114), Shanghai, Not set

Henan Cancer Hospital ( Site 0107), Zhengzhou, Not set

Rodrigo Botero SAS ( Site 2703), Medellin, Antioquia

Oncomedica S.A. ( Site 2701), Monteria, Cordoba

CIMCA Centro de Investigacion y Manejo del Cancer ( Site 2600), San Jose, Not set

Policlinico San Bosco ( Site 2602), San Jose, Not set

ICIMED - Instituto de Investigacion en Ciencias Medicas ( Site 2601), San Jose, Not set

Rigshospitalet ( Site 2301), Copenhagen, Not set

Odense Universitetshospital ( Site 2300), Odense, Not set

Centre Leon Berard ( Site 0307), Lyon, Cedex 8

CHU Brest - Institut de Cancerologie et d Hematologie ( Site 0305), Brest, Not set

Centre Francois Baclesse ( Site 0310), Caen, Not set

Centre Oscar Lambret ( Site 0304), Lille, Not set

Institut du Cancer de Montpellier ( Site 0306), Montpellier, Not set

CHU de Nantes - Hotel Dieu ( Site 0303), Nantes Cedex 1, Not set

Institut Mutualiste Montsouris ( Site 0300), Paris, Not set

CHU de Saint Etienne Hopital Nord ( Site 0309), Saint Etienne, Not set

Staedtisches Klinikum Dresden ( Site 1507), Dresden, Not set

Haematologisch-Onkologische Praxis Eppendorf Facharztzentrum Eppendorf - Hope ( Site 1502), Hamburg, Not set

Universitaetsklinikum Leipzig ( Site 1501), Leipzig, Not set

Klinikum Ludwigsburg ( Site 1509), Ludwigsburg, Not set

Universitatsklinikum Mannheim GmbH ( Site 1504), Mannheim, Not set

Klinik fuer Haematologie. Onkologie und Gastroenterologie ( Site 1508), Moenchengladbach, Not set

III. Medizinische Klinik Klinikum rechts der Isar ( Site 1506), Munchen, Not set

Centro de Investigacion Oncologica ( Site 1402), Guatemala, Not set

Oncomedica ( Site 1400), Guatemala, Not set

Grupo Medico Angeles ( Site 1401), Guatemala, Not set

Medi-K Cayala ( Site 1404), Guatemala, Not set

Centro Regional de Sub Especialidades Medicas SA ( Site 1403), Quetzaltenango, Not set

Humanity Health Research Centre ( Site 1603), Hong Kong, Not set

Pamela Youde Nethersole Eastern Hospital ( Site 1601), Hong Kong, Not set

Princess Margaret Hospital. ( Site 1602), Hong Kong, Not set

Queen Mary Hospital ( Site 1600), Hong Kong, Not set

Aichi Cancer Center Hospital ( Site 0902), Nagoya, Aichi

National Cancer Center Hospital East ( Site 0908), Kashiwa, Chiba

National Hospital Organization Shikoku Cancer Center ( Site 0901), Matsuyama, Ehime

Hokkaido University Hospital ( Site 0916), Sapporo, Hokkaido

Hyogo Cancer Center ( Site 0913), Akashi, Hyogo

Kobe City Medical Center General Hospital ( Site 0929), Kobe, Hyogo

Ibaraki Prefectural Central Hospital ( Site 0918), Kasama, Ibaraki

University of Tsukuba Hospital ( Site 0910), Tsukuba, Ibaraki

Kagawa University Hospital ( Site 0915), Kita-gun, Kagawa

St. Marianna University School of Medicine Hospital ( Site 0903), Kawasaki, Kanagawa

Kanagawa Cancer Center ( Site 0921), Yokohama, Kanagawa

Oita University Hospital ( Site 0930), Yufu, Oita

Kansai Medical University Hospital ( Site 0931), Hirakata, Osaka

Kindai University Hospital ( Site 0917), Osakasayama, Osaka

Osaka University Hospital ( Site 0911), Suita, Osaka

Osaka Medical College Hospital ( Site 0925), Takatsuki, Osaka

Saitama Cancer Center ( Site 0926), Kitaadachi-gun, Saitama

Shizuoka Cancer Center Hospital and Research Institute ( Site 0914), Sunto-gun, Shizuoka

Kyorin University Hospital ( Site 0905), Mitaka, Tokyo

Chiba University Hospital ( Site 0909), Chiba, Not set

Chiba Cancer Center ( Site 0900), Chiba, Not set

National Hospital Organization Kyushu Cancer Center ( Site 0906), Fukuoka, Not set

Kyushu University Hospital ( Site 0922), Fukuoka, Not set

Gifu University Hospital ( Site 0920), Gifu, Not set

Kumamoto University Hospital ( Site 0919), Kumamoto, Not set

Niigata Cancer Center Hospital ( Site 0924), Niigata, Not set

Osaka International Cancer Institute ( Site 0923), Osaka, Not set

Osaka General Medical Center ( Site 0912), Osaka, Not set

National Cancer Center Hospital ( Site 0907), Tokyo, Not set

The Cancer Institute Hospital of JFCR ( Site 0904), Tokyo, Not set

Keio University Hospital ( Site 0927), Tokyo, Not set

National Cancer Center ( Site 1304), Goyang-si, Gyeonggi-do

Chonnam National University Hwasun Hospital ( Site 1305), Hwasun Gun, Jeollanam Do

Seoul National University Cancer Hospital ( Site 1301), Seoul, Not set

Severance Hospital Yonsei University Health System ( Site 1302), Seoul, Not set

Asan Medical Center ( Site 1303), Seoul, Not set

Samsung Medical Center ( Site 1300), Seoul, Not set

Beacon International Specialist Centre ( Site 1803), Petaling Jaya, Selangor

Hospital Kuala Lumpur ( Site 1805), Kuala Lumpur, Not set

University Malaya Medical Centre ( Site 1802), Kuala Lumpur, Not set

Instituto Regional de Enfermedades Neoplasicas del Sur IRENSUR ( Site 1702), Arequipa, Not set

Hospital Nacional Guillermo Almenara Irigoyen ( Site 1701), Lima, Not set

Instituto Nacional de Enfermedades Neoplasicas ( Site 1705), Lima, Not set

S C Pelican Impex SRL ( Site 2403), Oradea, Bihor

S.C. Radiotherapy Center Cluj S.R.L ( Site 2407), Comuna Floresti, Cluj

S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 2404), Craiova, Dolj

S.C.Focus Lab Plus S.R.L ( Site 2401), Bucuresti, Sector 2

S C Oncocenter Oncologie Medicala S R L ( Site 2405), Timisoara, Timis

S.C.Gral Medical S.R.L ( Site 2406), Bucuresti, Not set

Spitalul Clinic Judetean De Urgenta Constanta ( Site 2402), Constanta, Not set

SBHCI RCOD of MHC RB ( Site 0407), Ufa, Republic Of Bashkortostan

Leningrad Regional Oncology Center ( Site 0405), Saint-Petersburg, Vsevolzhsk District

National Medical and Surgical Center n.a. N.I.Pirogov ( Site 0402), Moscow, Not set

N.N. Blokhin NMRCO ( Site 0401), Moscow, Not set

Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 0406), Saint-Petersburg, Not set

St Petersburg City Clinical Oncology Dispensary ( Site 0409), St. Petersburg, Not set

Tomsk Scientific Research Institute of Oncology ( Site 0403), Tomsk, Not set

Cancer Care Langenhoven Drive Oncology Centre ( Site 2501), Port Elizabeth, Eastern Cape

The Medical Oncology Centre of Rosebank ( Site 2506), Johannesburg, Gauteng

WITS Clinical Research CMJAH Clinical Trial Site ( Site 2500), Parktown, Gauteng

The Oncology Centre ( Site 2502), Durban, Kwa-Zulu Natal

Cape Town Oncology Trials Pty Ltd ( Site 2508), Cape Town, Western Cape

Outeniqua Cancercare Oncology Unit ( Site 2504), George, Western Cape

Clinton Oncology Centre ( Site 2505), Alberton, Not set

Hospital Universitario Central de Asturias ( Site 0708), Oviedo, Asturias

Hosp. Gral. Universitari Germans Trias i Pujol ( Site 0701), Badalona, Barcelona

Hospital Universitari Vall d Hebron ( Site 0702), Barcelona, Not set

Hospital Universitario Reina Sofia ( Site 0706), Cordoba, Not set

Hospital Ramon y Cajal ( Site 0703), Madrid, Not set

Hospital Universitario La Paz ( Site 0700), Madrid, Not set

Complejo Hospitalario Virgen De La Victoria ( Site 0705), Malaga, Not set

Chang Gung Med Foundation. Kaohsiung Branch ( Site 1906), Kaohsiung, Not set

Taipei Medical University Shuang Ho Hospital ( Site 1908), New Taipei, Not set

China Medical University Hospital ( Site 1904), Taichung, Not set

Kuang Tien General Hospital ( Site 1909), Taichung, Not set

National Cheng Kung University Hospital ( Site 1905), Tainan, Not set

Chi Mei Medical Center Liuying ( Site 1907), Tainan, Not set

National Taiwan University Hospital ( Site 1900), Taipei, Not set

Koo Foundation Sun Yat-Sen Cancer Center ( Site 1902), Taipei, Not set

Chang Gung Medical Foundation. Linkou ( Site 1903), Taoyuan, Not set

Bumrungrad International Hospital ( Site 2203), Bangkok, Not set

Chulalongkorn Hospital ( Site 2201), Bangkok, Not set

Ramathibodi Hospital. ( Site 2202), Bangkok, Not set

Phramongkutklao Hospital ( Site 2205), Bangkok, Not set

Songklanagarind Hospital ( Site 2204), Songkla, Not set

Adana Sehir Hastanesi ( Site 0802), Adana, Not set

Ankara Sehir Hastanesi ( Site 0808), Ankara, Not set

Istanbul Medeniyet Universitesi Goztepe EAH ( Site 0807), Istanbul, Not set

Istanbul Universitesi Cerrahpasa Tip Fakultesi ( Site 0804), Istanbul, Not set

Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi ( Site 0801), Istanbul, Not set

Medical Park Izmir Hastanesi ( Site 0800), Izmir, Not set

Inonu Universitesi Turgut Ozal Tip Merkezi ( Site 0803), Malatya, Not set

Lothian University Hospitals NHS Trust ( Site 1101), Edinburgh, Mid Lothian

St Luke's Cancer Centre ( Site 1102), Guildford, Not set

The Christie NHS Foundation Trust ( Site 1100), Manchester, Not set

Conditions: Esophageal Neoplasms

Learn More ›

Browse by State

Cisplatin treatment options in Alabama

Cisplatin treatment options in Alaska

Cisplatin treatment options in Arizona

Cisplatin treatment options in Arkansas

Cisplatin treatment options in California

Cisplatin treatment options in Colorado

Cisplatin treatment options in Connecticut

Cisplatin treatment options in Delaware

Cisplatin treatment options in District of Columbia

Cisplatin treatment options in Florida

Cisplatin treatment options in Georgia

Cisplatin treatment options in Hawaii

Cisplatin treatment options in Idaho

Cisplatin treatment options in Illinois

Cisplatin treatment options in Indiana

Cisplatin treatment options in Iowa

Cisplatin treatment options in Kansas

Cisplatin treatment options in Kentucky

Cisplatin treatment options in Louisiana

Cisplatin treatment options in Maine

Cisplatin treatment options in Montana

Cisplatin treatment options in Nebraska

Cisplatin treatment options in Nevada

Cisplatin treatment options in New Hampshire

Cisplatin treatment options in New Jersey

Cisplatin treatment options in New Mexico

Cisplatin treatment options in New York

Cisplatin treatment options in North Carolina

Cisplatin treatment options in North Dakota

Cisplatin treatment options in Ohio

Cisplatin treatment options in Oklahoma

Cisplatin treatment options in Oregon

Cisplatin treatment options in Maryland

Cisplatin treatment options in Massachusetts

Cisplatin treatment options in Michigan

Cisplatin treatment options in Minnesota

Cisplatin treatment options in Mississippi

Cisplatin treatment options in Missouri

Cisplatin treatment options in Pennsylvania

Cisplatin treatment options in Rhode Island

Cisplatin treatment options in South Carolina

Cisplatin treatment options in South Dakota

Cisplatin treatment options in Tennessee

Cisplatin treatment options in Texas

Cisplatin treatment options in Utah

Cisplatin treatment options in Vermont

Cisplatin treatment options in Virginia

Cisplatin treatment options in Washington

Cisplatin treatment options in West Virginia

Cisplatin treatment options in Wisconsin

Cisplatin treatment options in Wyoming